Cidara Therapeutics Ownership 2024 | Who Owns Cidara Therapeutics Now?
Institutional Ownership
0.09%
Insider Ownership
4.76%
Retail Ownership
95.16%
Institutional Holders
1.00
Cidara Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WETZEL INVESTMENT ADVISORS, INC. | 0.09% | 0.00% | 4,000 | - | - | 3,680 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -451 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -262,072 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -643 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -160,356 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -271,537 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -3,346,260 | -100.00% | - | Jun 30, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -163,000 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -26,814 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -15,598 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -39,290 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -2,554,973 | -100.00% | - | Jun 30, 2024 |
| BVF INC/IL | - | - | - | -6,861,127 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -60,060 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -353 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -67,245 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -838,286 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -456,606 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -715,410 | -100.00% | - | Jun 30, 2024 |
Cidara Therapeutics's largest institutional shareholder is WETZEL INVESTMENT ADVISORS, INC., holding 0.09% of the company's total share outstanding, currently valued at $3.68K. The top 10 institutional shareholders own together 0.09% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WETZEL INVESTMENT ADVISORS, INC. | 0.09% | 0.00% | 4,000 | - | - | 3,680 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -451 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -262,072 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -643 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -160,356 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -271,537 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -3,346,260 | -100.00% | - | Jun 30, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -163,000 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -26,814 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -15,598 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -39,290 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -2,554,973 | -100.00% | - | Jun 30, 2024 |
| BVF INC/IL | - | - | - | -6,861,127 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -60,060 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -353 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -67,245 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -838,286 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -456,606 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -715,410 | -100.00% | - | Jun 30, 2024 |
The largest Cidara Therapeutics shareholder by % of total assets is WETZEL INVESTMENT ADVISORS, INC.. The company owns 4.00K shares of Cidara Therapeutics (CDTX), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WETZEL INVESTMENT ADVISORS, INC. | 0.09% | 0.00% | 4,000 | - | - | 3,680 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -52 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -290 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -353 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -451 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -643 | -100.00% | - | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | - | -800 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -4,695 | -100.00% | - | Jun 30, 2024 |
| PACIFICA PARTNERS INC. | - | - | - | -8,000 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -9,048 | -100.00% | - | Jun 30, 2024 |
| SPIRE WEALTH MANAGEMENT | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| MARINER, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| PURE FINANCIAL ADVISORS, LLC | - | - | - | -11,500 | -100.00% | - | Jun 30, 2024 |
| LIBERTY WEALTH MANAGEMENT LLC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -15,598 | -100.00% | - | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -17,100 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -26,814 | -100.00% | - | Jun 30, 2024 |
| LEGACY WEALTH ASSET MANAGEMENT, LLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -39,290 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Cidara Therapeutics's largest institutional buyer is WETZEL INVESTMENT ADVISORS, INC.. The company purchased 0.00 stocks of CDTX, valued at $3.68K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -6,861,127 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -3,346,260 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -2,554,973 | -100.00% | - | Jun 30, 2024 |
| ALETHEA CAPITAL MANAGEMENT, LLC | - | - | - | -1,598,492 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -1,250,000 | -100.00% | - | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | - | - | - | -1,134,511 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -838,286 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -715,410 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -552,000 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -456,606 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -369,099 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -316,835 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -271,537 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -262,072 | -100.00% | - | Jun 30, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -163,000 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -160,356 | -100.00% | - | Jun 30, 2024 |
| JEPPSON WEALTH MANAGEMENT, LLC | - | - | - | -148,650 | -100.00% | - | Jun 30, 2024 |
| WEST MICHIGAN ADVISORS, LLC | - | - | - | -135,000 | -100.00% | - | Jun 30, 2024 |
| CALLAN CAPITAL, LLC | - | - | - | -95,169 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -79,012 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Cidara Therapeutics's biggest institutional seller is BVF INC/IL. The company sold -6.86M shares of CDTX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -6,861,127 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -3,346,260 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -2,554,973 | -100.00% | - | Jun 30, 2024 |
| ALETHEA CAPITAL MANAGEMENT, LLC | - | - | - | -1,598,492 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -1,250,000 | -100.00% | - | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | - | - | - | -1,134,511 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -838,286 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -715,410 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -552,000 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -456,606 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -369,099 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -316,835 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -271,537 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -262,072 | -100.00% | - | Jun 30, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -163,000 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -160,356 | -100.00% | - | Jun 30, 2024 |
| JEPPSON WEALTH MANAGEMENT, LLC | - | - | - | -148,650 | -100.00% | - | Jun 30, 2024 |
| WEST MICHIGAN ADVISORS, LLC | - | - | - | -135,000 | -100.00% | - | Jun 30, 2024 |
| CALLAN CAPITAL, LLC | - | - | - | -95,169 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -79,012 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -77,553 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -67,245 | -100.00% | - | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | - | - | - | -66,549 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -60,060 | -100.00% | - | Jun 30, 2024 |
| FNY INVESTMENT ADVISERS, LLC | - | - | - | -56,600 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -52,642 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -39,290 | -100.00% | - | Jun 30, 2024 |
| LEGACY WEALTH ASSET MANAGEMENT, LLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -26,814 | -100.00% | - | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -17,100 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -15,598 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| LIBERTY WEALTH MANAGEMENT LLC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| PURE FINANCIAL ADVISORS, LLC | - | - | - | -11,500 | -100.00% | - | Jun 30, 2024 |
| MARINER, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| SPIRE WEALTH MANAGEMENT | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -9,048 | -100.00% | - | Jun 30, 2024 |
| PACIFICA PARTNERS INC. | - | - | - | -8,000 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -4,695 | -100.00% | - | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | - | -800 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -643 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -451 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -353 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -290 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -52 | -100.00% | - | Jun 30, 2024 |
Cidara Therapeutics's largest sold out institutional shareholder by shares sold is BVF INC/IL, sold -6.86M shares, valued at -, as of undefined.
Cidara Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA LIFE SCIENCES INVESTORS | 0.41% | 195,256 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.11% | 59,329 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 60,060 | - | - | Mar 28, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,224 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 54,478 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.01% | 6,300 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.01% | 3,214,289 | -1,047,746 | -24.58% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 19,538 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 766,205 | 29,111 | 3.95% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 54,780 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,951 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 5,607 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 4,501 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 26,814 | - | - | Jan 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 19,270 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 18,221 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 290 | - | - | Apr 30, 2021 |
| Destra Investment Trust | 0.00% | 682 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 49,101 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 15,599 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 14,886 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 43,806 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 42,790 | - | - | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 44,444 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 19,127 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 6,700 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 6,310 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 92,768 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 777 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 17,102 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 117,947 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 5,998 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,400 | - | - | Mar 28, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 9,026 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,954 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 104,749 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 128,141 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 2,057 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 45,100 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,796 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 394 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 13,235 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 181,075 | -5,303 | -2.85% | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,897 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 6,454 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 4,889 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 15,831 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 10,992 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 4,335 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 5,630 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 5,117 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 1,880 | - | - | Mar 28, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 519 | - | - | Mar 31, 2024 |
Cidara Therapeutics's largest mutual fund holder by % of total assets is "TEKLA LIFE SCIENCES INVESTORS", owning 195.26K shares, compromising 0.41% of its total assets.
Cidara Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -98.04% |
| 31 Mar, 24 | 51 | 2.00% |
| 31 Dec, 23 | 50 | -9.09% |
| 30 Sep, 23 | 55 | 1.85% |
| 30 Jun, 23 | 54 | - |
| 31 Mar, 23 | 54 | 35.00% |
| 31 Dec, 22 | 40 | - |
| 30 Sep, 22 | 40 | -2.44% |
| 30 Jun, 22 | 41 | -2.38% |
| 31 Mar, 22 | 42 | -19.23% |
| 31 Dec, 21 | 52 | - |
| 30 Sep, 21 | 52 | -8.77% |
| 30 Jun, 21 | 57 | -8.06% |
| 31 Mar, 21 | 62 | -1.59% |
| 31 Dec, 20 | 63 | -5.97% |
| 30 Sep, 20 | 67 | 1.52% |
| 30 Jun, 20 | 66 | 26.92% |
| 31 Mar, 20 | 52 | - |
| 31 Dec, 19 | 52 | 44.44% |
| 30 Sep, 19 | 36 | -18.18% |
| 30 Jun, 19 | 44 | -12.00% |
| 31 Mar, 19 | 50 | 2.04% |
| 31 Dec, 18 | 49 | -19.67% |
| 30 Sep, 18 | 61 | 7.02% |
| 30 Jun, 18 | 57 | -9.52% |
| 31 Mar, 18 | 63 | 31.25% |
| 31 Dec, 17 | 48 | 14.29% |
| 30 Sep, 17 | 42 | -22.22% |
| 30 Jun, 17 | 54 | 3.85% |
| 31 Mar, 17 | 52 | -8.77% |
| 31 Dec, 16 | 57 | 11.76% |
| 30 Sep, 16 | 51 | -8.93% |
| 30 Jun, 16 | 56 | 21.74% |
| 31 Mar, 16 | 46 | 2.22% |
| 31 Dec, 15 | 45 | - |
| 30 Sep, 15 | 45 | - |
| 30 Jun, 15 | 45 | - |
As of 30 Jun 24, 1 institutions are holding Cidara Therapeutics's shares, representing a decrease of -98.04% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 4,000 | -99.98% |
| 31 Mar, 24 | 22,055,850 | -4.85% |
| 31 Dec, 23 | 23,179,993 | -3.72% |
| 30 Sep, 23 | 24,074,750 | -8.31% |
| 30 Jun, 23 | 26,255,381 | -3.15% |
| 31 Mar, 23 | 27,108,748 | 1.78% |
| 31 Dec, 22 | 26,634,589 | -1.62% |
| 30 Sep, 22 | 27,072,192 | -0.52% |
| 30 Jun, 22 | 27,214,045 | -10.22% |
| 31 Mar, 22 | 30,313,114 | -2.51% |
| 31 Dec, 21 | 31,094,065 | 54.78% |
| 30 Sep, 21 | 20,089,066 | 0.20% |
| 30 Jun, 21 | 20,048,957 | -5.85% |
| 31 Mar, 21 | 21,295,477 | -12.26% |
| 31 Dec, 20 | 24,270,954 | -9.10% |
| 30 Sep, 20 | 26,700,383 | 6.40% |
| 30 Jun, 20 | 25,093,685 | 11.89% |
| 31 Mar, 20 | 22,426,555 | 36.06% |
| 31 Dec, 19 | 16,483,032 | 13.93% |
| 30 Sep, 19 | 14,468,251 | -8.72% |
| 30 Jun, 19 | 15,849,813 | -1.38% |
| 31 Mar, 19 | 16,071,007 | -9.07% |
| 31 Dec, 18 | 17,674,910 | -4.84% |
| 30 Sep, 18 | 18,574,521 | -2.54% |
| 30 Jun, 18 | 19,059,489 | 39.03% |
| 31 Mar, 18 | 13,708,484 | -8.17% |
| 31 Dec, 17 | 14,927,590 | 33.08% |
| 30 Sep, 17 | 11,216,645 | 0.65% |
| 30 Jun, 17 | 11,143,688 | -2.67% |
| 31 Mar, 17 | 11,449,074 | 0.48% |
| 31 Dec, 16 | 11,394,722 | 44.62% |
| 30 Sep, 16 | 7,878,815 | -3.55% |
| 30 Jun, 16 | 8,168,731 | -7.37% |
| 31 Mar, 16 | 8,818,628 | -1.32% |
| 31 Dec, 15 | 8,936,361 | -26.01% |
| 30 Sep, 15 | 12,077,303 | 103.40% |
| 30 Jun, 15 | 5,937,771 | - |
Cidara Therapeutics (CDTX) has 4.00K shares outstanding as of 30 Jun 24, down -99.98% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 0.09% | 0.01% |
| 31 Mar, 24 | 24.43% | 3.71% |
| 31 Dec, 23 | 25.67% | 3.60% |
| 30 Sep, 23 | 26.72% | 2.40% |
| 30 Jun, 23 | 33.39% | 2.81% |
| 31 Mar, 23 | 34.47% | 2.51% |
| 31 Dec, 22 | 37.05% | 2.49% |
| 30 Sep, 22 | 38.55% | 2.49% |
| 30 Jun, 22 | 39.36% | 1.99% |
| 31 Mar, 22 | 44.49% | 1.27% |
| 31 Dec, 21 | 59.28% | 3.60% |
| 30 Sep, 21 | 40.56% | 2.39% |
| 30 Jun, 21 | 41.19% | 2.00% |
| 31 Mar, 21 | 45.34% | 1.44% |
| 31 Dec, 20 | 56.17% | 1.47% |
| 30 Sep, 20 | 61.79% | 1.65% |
| 30 Jun, 20 | 61.26% | 1.75% |
| 31 Mar, 20 | 59.24% | 1.95% |
| 31 Dec, 19 | 55.06% | 2.87% |
| 30 Sep, 19 | 43.83% | 1.35% |
| 30 Jun, 19 | 57.04% | 1.70% |
| 31 Mar, 19 | 57.96% | 1.43% |
| 31 Dec, 18 | 63.62% | 1.42% |
| 30 Sep, 18 | 67.04% | 1.03% |
| 30 Jun, 18 | 80.79% | 1.88% |
| 31 Mar, 18 | 65.61% | 1.12% |
| 31 Dec, 17 | 76.59% | 1.73% |
| 30 Sep, 17 | 66.51% | 1.52% |
| 30 Jun, 17 | 66.21% | 1.42% |
| 31 Mar, 17 | 68.17% | 1.40% |
| 31 Dec, 16 | 69.68% | 2.17% |
| 30 Sep, 16 | 56.64% | 1.63% |
| 30 Jun, 16 | 58.89% | 1.44% |
| 31 Mar, 16 | 63.87% | 0.79% |
| 31 Dec, 15 | 90.08% | 1.15% |
| 30 Sep, 15 | 88.32% | 3.01% |
| 30 Jun, 15 | 54.19% | - |
As of 30 Jun 24, Cidara Therapeutics is held by 0.09% institutional shareholders, representing a 0.01% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | - | -100.00% |
| 31 Mar, 24 | 15 | -11.76% |
| 31 Dec, 23 | 17 | -15.00% |
| 30 Sep, 23 | 20 | -16.67% |
| 30 Jun, 23 | 24 | -31.43% |
| 31 Mar, 23 | 35 | 133.33% |
| 31 Dec, 22 | 15 | - |
| 30 Sep, 22 | 15 | - |
| 30 Jun, 22 | 15 | -16.67% |
| 31 Mar, 22 | 18 | -40.00% |
| 31 Dec, 21 | 30 | 42.86% |
| 30 Sep, 21 | 21 | -16.00% |
| 30 Jun, 21 | 25 | -13.79% |
| 31 Mar, 21 | 29 | -6.45% |
| 31 Dec, 20 | 31 | 3.33% |
| 30 Sep, 20 | 30 | -36.17% |
| 30 Jun, 20 | 47 | 11.90% |
| 31 Mar, 20 | 42 | 40.00% |
| 31 Dec, 19 | 30 | 130.77% |
| 30 Sep, 19 | 13 | -13.33% |
| 30 Jun, 19 | 15 | 25.00% |
| 31 Mar, 19 | 12 | -20.00% |
| 31 Dec, 18 | 15 | -44.44% |
| 30 Sep, 18 | 27 | -10.00% |
| 30 Jun, 18 | 30 | -18.92% |
| 31 Mar, 18 | 37 | 42.31% |
| 31 Dec, 17 | 26 | 73.33% |
| 30 Sep, 17 | 15 | -51.61% |
| 30 Jun, 17 | 31 | 19.23% |
| 31 Mar, 17 | 26 | -31.58% |
| 31 Dec, 16 | 38 | 72.73% |
| 30 Sep, 16 | 22 | -45.00% |
| 30 Jun, 16 | 40 | 110.53% |
| 31 Mar, 16 | 19 | -17.39% |
| 31 Dec, 15 | 23 | -14.81% |
| 30 Sep, 15 | 27 | -40.00% |
| 30 Jun, 15 | 45 | - |
- institutional shareholders have increased their position in CDTX stock as of 30 Jun 24 compared to 15 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | - | -100.00% |
| 31 Mar, 24 | 13 | 8.33% |
| 31 Dec, 23 | 12 | -14.29% |
| 30 Sep, 23 | 14 | 16.67% |
| 30 Jun, 23 | 12 | 100.00% |
| 31 Mar, 23 | 6 | -14.29% |
| 31 Dec, 22 | 7 | -41.67% |
| 30 Sep, 22 | 12 | 9.09% |
| 30 Jun, 22 | 11 | -8.33% |
| 31 Mar, 22 | 12 | - |
| 31 Dec, 21 | 12 | -25.00% |
| 30 Sep, 21 | 16 | -27.27% |
| 30 Jun, 21 | 22 | 15.79% |
| 31 Mar, 21 | 19 | 11.76% |
| 31 Dec, 20 | 17 | -15.00% |
| 30 Sep, 20 | 20 | 150.00% |
| 30 Jun, 20 | 8 | 100.00% |
| 31 Mar, 20 | 4 | -33.33% |
| 31 Dec, 19 | 6 | -50.00% |
| 30 Sep, 19 | 12 | -14.29% |
| 30 Jun, 19 | 14 | -26.32% |
| 31 Mar, 19 | 19 | 58.33% |
| 31 Dec, 18 | 12 | 9.09% |
| 30 Sep, 18 | 11 | - |
| 30 Jun, 18 | 11 | - |
| 31 Mar, 18 | 11 | 22.22% |
| 31 Dec, 17 | 9 | -18.18% |
| 30 Sep, 17 | 11 | -15.38% |
| 30 Jun, 17 | 13 | - |
| 31 Mar, 17 | 13 | 116.67% |
| 31 Dec, 16 | 6 | -45.45% |
| 30 Sep, 16 | 11 | 22.22% |
| 30 Jun, 16 | 9 | -10.00% |
| 31 Mar, 16 | 10 | -28.57% |
| 31 Dec, 15 | 14 | 100.00% |
| 30 Sep, 15 | 7 | - |
| 30 Jun, 15 | - | - |
- institutional shareholders have reduced their position in CDTX stock as of 30 Jun 24 compared to 13 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 1 | -98.04% | 4,000 | -99.98% | 0.09% | 0.01% | - | -100.00% | - | -100.00% |
| 31 Mar, 24 | 51 | 2.00% | 22,055,850 | -4.85% | 24.43% | 3.71% | 15 | -11.76% | 13 | 8.33% |
| 31 Dec, 23 | 50 | -9.09% | 23,179,993 | -3.72% | 25.67% | 3.60% | 17 | -15.00% | 12 | -14.29% |
| 30 Sep, 23 | 55 | 1.85% | 24,074,750 | -8.31% | 26.72% | 2.40% | 20 | -16.67% | 14 | 16.67% |
| 30 Jun, 23 | 54 | - | 26,255,381 | -3.15% | 33.39% | 2.81% | 24 | -31.43% | 12 | 100.00% |
| 31 Mar, 23 | 54 | 35.00% | 27,108,748 | 1.78% | 34.47% | 2.51% | 35 | 133.33% | 6 | -14.29% |
| 31 Dec, 22 | 40 | - | 26,634,589 | -1.62% | 37.05% | 2.49% | 15 | - | 7 | -41.67% |
| 30 Sep, 22 | 40 | -2.44% | 27,072,192 | -0.52% | 38.55% | 2.49% | 15 | - | 12 | 9.09% |
| 30 Jun, 22 | 41 | -2.38% | 27,214,045 | -10.22% | 39.36% | 1.99% | 15 | -16.67% | 11 | -8.33% |
| 31 Mar, 22 | 42 | -19.23% | 30,313,114 | -2.51% | 44.49% | 1.27% | 18 | -40.00% | 12 | - |
| 31 Dec, 21 | 52 | - | 31,094,065 | 54.78% | 59.28% | 3.60% | 30 | 42.86% | 12 | -25.00% |
| 30 Sep, 21 | 52 | -8.77% | 20,089,066 | 0.20% | 40.56% | 2.39% | 21 | -16.00% | 16 | -27.27% |
| 30 Jun, 21 | 57 | -8.06% | 20,048,957 | -5.85% | 41.19% | 2.00% | 25 | -13.79% | 22 | 15.79% |
| 31 Mar, 21 | 62 | -1.59% | 21,295,477 | -12.26% | 45.34% | 1.44% | 29 | -6.45% | 19 | 11.76% |
| 31 Dec, 20 | 63 | -5.97% | 24,270,954 | -9.10% | 56.17% | 1.47% | 31 | 3.33% | 17 | -15.00% |
| 30 Sep, 20 | 67 | 1.52% | 26,700,383 | 6.40% | 61.79% | 1.65% | 30 | -36.17% | 20 | 150.00% |
| 30 Jun, 20 | 66 | 26.92% | 25,093,685 | 11.89% | 61.26% | 1.75% | 47 | 11.90% | 8 | 100.00% |
| 31 Mar, 20 | 52 | - | 22,426,555 | 36.06% | 59.24% | 1.95% | 42 | 40.00% | 4 | -33.33% |
| 31 Dec, 19 | 52 | 44.44% | 16,483,032 | 13.93% | 55.06% | 2.87% | 30 | 130.77% | 6 | -50.00% |
| 30 Sep, 19 | 36 | -18.18% | 14,468,251 | -8.72% | 43.83% | 1.35% | 13 | -13.33% | 12 | -14.29% |
| 30 Jun, 19 | 44 | -12.00% | 15,849,813 | -1.38% | 57.04% | 1.70% | 15 | 25.00% | 14 | -26.32% |
| 31 Mar, 19 | 50 | 2.04% | 16,071,007 | -9.07% | 57.96% | 1.43% | 12 | -20.00% | 19 | 58.33% |
| 31 Dec, 18 | 49 | -19.67% | 17,674,910 | -4.84% | 63.62% | 1.42% | 15 | -44.44% | 12 | 9.09% |
| 30 Sep, 18 | 61 | 7.02% | 18,574,521 | -2.54% | 67.04% | 1.03% | 27 | -10.00% | 11 | - |
| 30 Jun, 18 | 57 | -9.52% | 19,059,489 | 39.03% | 80.79% | 1.88% | 30 | -18.92% | 11 | - |
| 31 Mar, 18 | 63 | 31.25% | 13,708,484 | -8.17% | 65.61% | 1.12% | 37 | 42.31% | 11 | 22.22% |
| 31 Dec, 17 | 48 | 14.29% | 14,927,590 | 33.08% | 76.59% | 1.73% | 26 | 73.33% | 9 | -18.18% |
| 30 Sep, 17 | 42 | -22.22% | 11,216,645 | 0.65% | 66.51% | 1.52% | 15 | -51.61% | 11 | -15.38% |
| 30 Jun, 17 | 54 | 3.85% | 11,143,688 | -2.67% | 66.21% | 1.42% | 31 | 19.23% | 13 | - |
| 31 Mar, 17 | 52 | -8.77% | 11,449,074 | 0.48% | 68.17% | 1.40% | 26 | -31.58% | 13 | 116.67% |
| 31 Dec, 16 | 57 | 11.76% | 11,394,722 | 44.62% | 69.68% | 2.17% | 38 | 72.73% | 6 | -45.45% |
| 30 Sep, 16 | 51 | -8.93% | 7,878,815 | -3.55% | 56.64% | 1.63% | 22 | -45.00% | 11 | 22.22% |
| 30 Jun, 16 | 56 | 21.74% | 8,168,731 | -7.37% | 58.89% | 1.44% | 40 | 110.53% | 9 | -10.00% |
| 31 Mar, 16 | 46 | 2.22% | 8,818,628 | -1.32% | 63.87% | 0.79% | 19 | -17.39% | 10 | -28.57% |
| 31 Dec, 15 | 45 | - | 8,936,361 | -26.01% | 90.08% | 1.15% | 23 | -14.81% | 14 | 100.00% |
| 30 Sep, 15 | 45 | - | 12,077,303 | 103.40% | 88.32% | 3.01% | 27 | -40.00% | 7 | - |
| 30 Jun, 15 | 45 | - | 5,937,771 | - | 54.19% | - | 45 | - | - | - |
Cidara Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Cidara Therapeutics's stock was made by RA CAPITAL MANAGEMENT, L.P. on Jul 22 2024, selling 10,044 shares at - per share (valued at -). The last insider buy of CDTX was made by Stein Jeffrey on Jun 11 2024, buying 8,000 shares at $13.21 per share (worth $105.68K).
Cidara Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 9 | - | - |
| Q2 2024 | 5 | - | - |
| Q1 2024 | 9 | 5 | 180.00% |
| Q3 2023 | 2 | 2 | 100.00% |
| Q2 2023 | 7 | - | - |
| Q1 2023 | 11 | 5 | 220.00% |
| Q3 2022 | 1 | 5 | 20.00% |
| Q2 2022 | 14 | - | - |
| Q1 2022 | 17 | 8 | 212.50% |
| Q4 2021 | 7 | 7 | 100.00% |
| Q3 2021 | 13 | 11 | 118.18% |
| Q2 2021 | 8 | 3 | 266.67% |
| Q1 2021 | 14 | 4 | 350.00% |
| Q4 2020 | 2 | - | - |
| Q2 2020 | 5 | - | - |
| Q1 2020 | 12 | 8 | 150.00% |
| Q4 2019 | 13 | 11 | 118.18% |
| Q3 2019 | 11 | 10 | 110.00% |
| Q2 2019 | 5 | - | - |
| Q1 2019 | 15 | 3 | 500.00% |
9 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cidara Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | 1 | - | - |
| Q1 2024 | - | 4 | - |
| Q3 2023 | 2 | 2 | 100.00% |
| Q2 2023 | - | - | - |
| Q1 2023 | 1 | 5 | 20.00% |
| Q3 2022 | - | 4 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 5 | - |
| Q4 2021 | 2 | - | - |
| Q3 2021 | 3 | - | - |
| Q2 2021 | - | 3 | - |
| Q1 2021 | - | 3 | - |
| Q4 2020 | 2 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | 5 | - |
| Q4 2019 | - | 2 | - |
| Q3 2019 | 3 | 1 | 300.00% |
| Q2 2019 | - | - | - |
| Q1 2019 | - | 2 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cidara Therapeutics's stocks.
CDTX Ownership FAQ
Who Owns Cidara Therapeutics?
Cidara Therapeutics is owned by institutional shareholders (0.09%), insiders (4.76%), and public (95.16%). The largest institutional shareholder of Cidara Therapeutics is WETZEL INVESTMENT ADVISORS, INC. (0.09% of total shares) and the top mutual fund owner is TEKLA LIFE SCIENCES INVESTORS (0.41% of total shares).
Who are the major institutional shareholders of Cidara Therapeutics?
Cidara Therapeutics's major institutional shareholders are WETZEL INVESTMENT ADVISORS, INC., JPMORGAN CHASE & CO, US BANCORP \DE\, WELLS FARGO & COMPANY/MN, and NORTHERN TRUST CORP. The top five shareholders own together 0.09% of the company's share outstanding.
How many Cidara Therapeutics shareholders are there?
As of Jun 2024, there are 1 institutional shareholders of Cidara Therapeutics.
What percentage of Cidara Therapeutics is owned by WETZEL INVESTMENT ADVISORS, INC?
WETZEL INVESTMENT ADVISORS, INC owns 4K shares of Cidara Therapeutics, representing 0.09% of the company's total shares outstanding, valued at $3.68K (as of Jun 2024).
What percentage of Cidara Therapeutics is owned by JPMORGAN CHASE & CO?
As of Jun 2024, JPMORGAN CHASE & CO holds 0 shares of Cidara Therapeutics (CDTX), compromising 0% of the company, valued at $0.
What percentage of Cidara Therapeutics is owned by US BANCORP \DE\?
US BANCORP \DE\ is the third largest holder of Cidara Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).